News

A new study has surprising findings about how seniors feel about healthcare and technology.

A new Oliver Wyman study reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.

A new study from Sage Growth Partners has shocking findings about EHRs and value-based care.

We know you’re pressed for time, so we’re here to help. Listen to this two-minute podcast for critical takeaways from three of our top articles.

A UCLA study shows that the Great Recession intensified patients’ cardiovascular risk factors.

FDA okayed the marketing of a new continuous glucose monitoring system for diabetics-the first to be used as part of an integrated system with other compatible medical devices and electronic interfaces.

There are a host of causes for a patient with chronic obstructive pulmonary disease (COPD) to be hospitalized, ranging from pneumonia to infection.

PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.

Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.

A new Symantec survey has surprising findings about risk assessment as a driver in cybersecurity investments.

FDA’s approval of a new combination treatment for patients with classical Hodgkin lymphoma (cHL) is the first new advanced treatment for the disease in 40 years

Due to problems with compounded medications- including the 2012 fungal meningitis outbreak that led to 64 deaths-FDA is releasing a draft guidance that will determine which bulk drug substances outsourcing facilities can use to compound drugs.

A revealing study shows what happens when urban Medicaid patients are offered complimentary rideshares to their primary care appointment.

The American Medical Association (AMA) is working to prevent new cases of type 2 diabetes-a leading cause of death and disability in the U.S. However, we know that we cannot do it alone.

A new study has eye-opening findings about home hospital care cost and patient experience.

Healthcare consumers want their digital customer experience to be similar to retail, according to revealing research findings from NTT DATA Services presented at HIMSS.

Eye-opening analysis from TransUnion Healthcare reveals patients continue to see rising costs.

Here are 10 important issues to consider when handling workplace harassment complaints.

President Donald Trump was expected to announce a new plan to combat the opioid crisis, even as a recent study found that prescription opioids were not as effective as over-the-counter medications for pain management.

As FDA considers new guidelines on pharmaceutical product marketing, a new study found that pharma makers may not be following current FDA ad regulations.

The new global DNA registry could help enable more precise treatments and identify who’s at risk for certain health problems.

Over the past few months, several new diabetes treatments have been approved by FDA. Here are the top 3 novel drugs for diabetes.

A new study shows efforts to reduce prescription opioid use in adults has not curtailed the incidence of pediatric opioid ingestions. Find out why.

Reduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.

Patients are the catalysts to interoperability changes, according to the Council of Accountable Physician Practices, an affiliate organization of the American Medical Group Foundation.

Before investing in new interoperability solutions, executives need to consider these four things.

When caring for cancer patients, improving care coordination in these two areas is key-and it can help reduce healthcare costs.

Unfortunately, the issue for many vets who experience trauma is that the mental health services they need are too far away from home. Here’s one solution.

About half of states have transitioned at least some Medicaid beneficiaries away from fee-for-service (FFS) drug programs into drug plans integrated with managed care. Our policy analyst shares why he believes more should do so.

A new FDA-approved drug offers new hope for patients with multidrug-resistant HIV-1 infection.